Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
130-89-2C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.ClLBSFSRMTJJPTCW-DSXUQNDKSA-NSicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (> 99.9%): Harmful if swallowed [Warning Acute toxicity, oral];H312 (91.3%): Harmful in contact with skin [Warning Acute toxicity, dermal];H332 (91.3%): Harmful if inhaled [Warning Acute toxicity, inhalation]
P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 1410 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Chemical: Cinchonan-9-ol, 6'-methoxy-, monohydrochloride, (8.alpha.,9R)-
Chemical: Cinchonan-9-ol, 6'-methoxy-, monohydrochloride, dihydrate, (8.alpha.,9R)-
Chemical: Cinchonan-9-ol, 6'-methoxy-, hydrochloride, (8.alpha.,9R)-
Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)
Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)
Cinchonan-9-ol, 6'-methoxy-, monohydrochloride, (8.alpha.,9R)-: Does not have an individual approval but may be used under an appropriate group standard
IMAP assessments - Quinine and its salts: Human health tier II assessment
IMAP assessments - Quinine and its salts: Human health tier II assessment
IMAP assessments - Quinine and its salts: Human health tier II assessment
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.
Cinchonan-9-ol, 6'-methoxy-, hydrochloride (1:1), (8.alpha.,9R)-: ACTIVE
Cinchonan-9-ol, 6'-methoxy-, hydrochloride (1:?), (8.alpha.,9R)-: INACTIVE
VerwendenANTI MALARIALS
Wird geladen…
130-89-2、60-93-5、6119-47-7、7549-43-1DTXSID7044213CHEMBL588046Acute Tox. 4 (> 99.9%);Acute Tox. 4 (91.3%);Acute Tox. 4 (91.3%)
Acute Tox. 4 (100%);Acute Tox. 4 (11.1%);Skin Sens. 1 (66.7%);Acute Tox. 4 (55.6%);Resp. Sens. 1 (44.4%)
Acute Tox. 4 (100%);Skin Sens. 1 (99.5%);Acute Tox. 4 (24.4%);Resp. Sens. 1 (75.1%)
Acute toxicity - category 4;Skin sensitisation - category 1
Acute toxicity - category 4;Skin sensitisation - category 1
Acute toxicity - category 4;Skin sensitisation - category 1
Chemical: Cinchonan-9-ol, 6'-methoxy-, monohydrochloride, (8.alpha.,9R)-
Chemical: Cinchonan-9-ol, 6'-methoxy-, monohydrochloride, dihydrate, (8.alpha.,9R)-
Chemical: Cinchonan-9-ol, 6'-methoxy-, hydrochloride, (8.alpha.,9R)-
Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)
Commission Regulation (EC) No 1565/2000 (Repealed by Com. Implementing Reg. (EU) No 872/2012)
Cinchonan-9-ol, 6'-methoxy-, monohydrochloride, (8.alpha.,9R)-: Does not have an individual approval but may be used under an appropriate group standard